Cancerappy ^Companies

Cancerappy is a biotech organization founded in 2019, headquartered in Bilbao, Spain. They specialize in the discovery and development of new therapeutic targets for cancer treatment using their own artificial intelligence methodology. Their platform, powered by big data and AI algorithms, helps identify new targets, lead compounds, and mechanisms of action for potential drugs. Cancerappy collaborates closely with innovative academic centers and focuses on the early stages of the drug discovery value chain, from target analysis to preclinical phases. Their innovative approach has led to a portfolio of drug programs, including PROTACs and nanotechnology-based compounds.